NO995229L - Anvendelse av sinkhyaluronat mot peptisk ulcus - Google Patents

Anvendelse av sinkhyaluronat mot peptisk ulcus

Info

Publication number
NO995229L
NO995229L NO995229A NO995229A NO995229L NO 995229 L NO995229 L NO 995229L NO 995229 A NO995229 A NO 995229A NO 995229 A NO995229 A NO 995229A NO 995229 L NO995229 L NO 995229L
Authority
NO
Norway
Prior art keywords
peptic ulcer
zinc hyaluronate
hyaluronate
daltons
molecular weight
Prior art date
Application number
NO995229A
Other languages
English (en)
Other versions
NO328313B1 (no
NO995229D0 (no
Inventor
Lsszlo Szporny
Gyula Szporny
Jsnos Illes
Judit Matuz
Erzsebet Neszmelyi
Gsborne Forrai
Bela Stefko
Katalin Ssghy
Original Assignee
Richter Gedeon Vegyeszeti Gysr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gysr filed Critical Richter Gedeon Vegyeszeti Gysr
Publication of NO995229D0 publication Critical patent/NO995229D0/no
Publication of NO995229L publication Critical patent/NO995229L/no
Publication of NO328313B1 publication Critical patent/NO328313B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19995229A 1997-04-29 1999-10-26 Fremgangsmate for fremstilling av et farmasoytisk preparat for oral anvendelse mot peptisk ulcus og anvendelse av sinkhyaluronatassosiat (-kompleks) med en molekylvekt i omradet fra 500 000 dalton til 1 200 000 dalton for fremstilling av farmasoytiske preparater for oral anvendelse mot peptisk ulcus NO328313B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
PCT/HU1998/000044 WO1998048815A1 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer

Publications (3)

Publication Number Publication Date
NO995229D0 NO995229D0 (no) 1999-10-26
NO995229L true NO995229L (no) 1999-12-22
NO328313B1 NO328313B1 (no) 2010-01-25

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995229A NO328313B1 (no) 1997-04-29 1999-10-26 Fremgangsmate for fremstilling av et farmasoytisk preparat for oral anvendelse mot peptisk ulcus og anvendelse av sinkhyaluronatassosiat (-kompleks) med en molekylvekt i omradet fra 500 000 dalton til 1 200 000 dalton for fremstilling av farmasoytiske preparater for oral anvendelse mot peptisk ulcus

Country Status (27)

Country Link
US (1) US6656921B1 (no)
EP (1) EP1017403B1 (no)
JP (1) JP2001522361A (no)
KR (1) KR100572190B1 (no)
CN (1) CN1126548C (no)
AT (1) ATE320814T1 (no)
BG (1) BG64458B1 (no)
BR (1) BR9809354A (no)
CA (1) CA2286756C (no)
CZ (1) CZ297317B6 (no)
DE (1) DE69833937T2 (no)
DK (1) DK1017403T3 (no)
EA (1) EA002134B1 (no)
EE (1) EE04953B1 (no)
ES (1) ES2259813T3 (no)
HK (1) HK1025250A1 (no)
HU (1) HU225991B1 (no)
IL (1) IL132214A0 (no)
NO (1) NO328313B1 (no)
NZ (1) NZ500978A (no)
PL (1) PL189526B1 (no)
PT (1) PT1017403E (no)
SK (1) SK284864B6 (no)
TW (1) TW501927B (no)
UA (1) UA62964C2 (no)
WO (1) WO1998048815A1 (no)
ZA (1) ZA983626B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
AU2006287321B2 (en) * 2005-09-09 2011-09-29 Bally Gaming, Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP6095014B2 (ja) * 2012-03-01 2017-03-15 キユーピー株式会社 浮腫抑制用経口剤
US20160287627A1 (en) * 2013-11-22 2016-10-06 Kewpie Corporation Method for suppressing onset of gastric ulcer as adverse effect of drug, oral pharmaceutical composition for suppressing onset of gastric ulcer and method for producing the same
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
WO1987005517A1 (en) * 1986-03-14 1987-09-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid useful as antimicrobial agents
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity

Also Published As

Publication number Publication date
NO328313B1 (no) 2010-01-25
EP1017403A1 (en) 2000-07-12
ES2259813T3 (es) 2006-10-16
HU9700826D0 (en) 1997-06-30
IL132214A0 (en) 2001-03-19
EE04953B1 (et) 2008-02-15
NO995229D0 (no) 1999-10-26
JP2001522361A (ja) 2001-11-13
DE69833937T2 (de) 2007-06-06
HU225991B1 (en) 2008-02-28
CN1254285A (zh) 2000-05-24
SK284864B6 (sk) 2006-01-05
US6656921B1 (en) 2003-12-02
PL336482A1 (en) 2000-06-19
PT1017403E (pt) 2006-07-31
EP1017403B1 (en) 2006-03-22
HUP9700826A1 (hu) 1998-12-28
EE9900470A (et) 2000-06-15
CZ382799A3 (cs) 2000-03-15
SK146899A3 (en) 2000-06-12
DK1017403T3 (da) 2006-07-31
EA002134B1 (ru) 2001-12-24
CZ297317B6 (cs) 2006-11-15
HK1025250A1 (en) 2000-11-10
BG64458B1 (bg) 2005-03-31
KR20010020413A (ko) 2001-03-15
ATE320814T1 (de) 2006-04-15
CA2286756C (en) 2008-02-19
NZ500978A (en) 2001-05-25
WO1998048815A1 (en) 1998-11-05
EA199900983A1 (ru) 2000-08-28
ZA983626B (en) 1998-11-05
PL189526B1 (pl) 2005-08-31
UA62964C2 (en) 2004-01-15
KR100572190B1 (ko) 2006-04-18
CA2286756A1 (en) 1998-11-05
DE69833937D1 (de) 2006-05-11
CN1126548C (zh) 2003-11-05
BG103822A (en) 2000-04-28
TW501927B (en) 2002-09-11
BR9809354A (pt) 2000-07-04

Similar Documents

Publication Publication Date Title
NO995229D0 (no) Anvendelse av sinkhyaluronat mot peptisk ulcus
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
NZ287335A (en) Copolymer-1 composition substantially free of species of copolymer -1 with a mw of from 4 kda to 8 kda, in particular 6.25 kda to 8.4 kda
FI970810A (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
CA2258920A1 (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
RU99107569A (ru) Фармацевтические композиции, обладающие антимикробной активностью
IT1290814B1 (it) Glicosaminoglicani aventi elevata attivita' antitrombotica
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
CA2247198A1 (en) Topical pharmaceutical composition containing heparin
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
CA2269031A1 (en) Treatment of urinary incontinence and compositions for use therein
CA2248753A1 (en) Use of olanzapine for treating excessive aggression
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
RU98108799A (ru) Обмазка садовая для заживления ран фруктовых и декоративных деревьев
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
MX9802268A (es) Nuevos derivados de la substancia pf1022 de ciclodepsipeptido.
PE61999A1 (es) Compuestos de tetrahidropiridina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees